Adult Autoimmune Myopathies (MAIA)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Brest

About this trial

This study corresponds to a monocentric prospective cohort of adult patients presenting a suspicion of idiopathic inflammatory myopathy. It will allows the constitution of an organized collection of longitudinal clinical data as well as collection of biological samples, including blood sample, urine, stool and muscle specimen.

Eligibility criteria

Qualifiers

Clinical suspicion of Adult Inflammatory Myopathy

Social security affiliation

Disqualifiers

Pregnant and lactating women

Patients unable to consent

Patients refusing to participate in the research.

Patients under legal protection

Trial design

Treatments tested in this trial

  • description of adult autoimmune myopathies

Treatment groups

60 Participants
are divided into 1 treatment group

Sponsors and collaborators